Antireflux surger y and risk of esophageal adenocarcinoma: A systematic review and meta-analysis

Annals of Surgery

Volumn 263, Issue 2, 2016, Pages 251-257

  Maret Ouda, John ^a   Konings, Peter ^a   Lagergren, Jesper ^a,b   Brusselaers, Nele ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Gastroesophageal reflux; Incidence; Neoplasm; Prevention

Indexed keywords

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK; SYSTEMATIC REVIEW; ADENOCARCINOMA; COMPARATIVE STUDY; COMPLICATION; ESOPHAGEAL NEOPLASMS; META ANALYSIS; POISSON DISTRIBUTION; RISK FACTOR; STATISTICAL MODEL; STOMACH FUNDOPLICATION; TREATMENT OUTCOME;

ANTACID AGENT; PROTON PUMP INHIBITOR;

ADENOCARCINOMA; ANTACIDS; ESOPHAGEAL NEOPLASMS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; MODELS, STATISTICAL; POISSON DISTRIBUTION; PROTON PUMP INHIBITORS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84955650387     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001438     Document Type: Article

References (34)

1. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
2. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013;310:627-636.
3. Edgren G, Adami HO, Weiderpass E, et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62:1406-1414.
4. Lagergren J, Lagergren P. Recent developments in esophageal adenocarci-noma. CA Cancer J Clin. 2013;63:232-248.
5. Hinder RA, Filipi CJ, Wetscher G, et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg. 1994;220:472-481; discussion 481-483.
6. Laine S, Rantala A, Gullichsen R, et al. Laparoscopic vs conventional Nissen fundoplication. A prospective randomized study. Surg Endosc. 1997;11:441-444.
7. Eshraghi N, Farahmand M, Soot SJ, et al. Comparison of outcomes of open versus laparoscopic Nissen fundoplication performed in a single practice. Am J Surg. 1998;175:371-374.
8. Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol. 2003;98:2390-2394.
9. Chang EY, Morris CD, Seltman AK, et al. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review. Ann Surg. 2007;246:11-21.
10. Csendes A. Results of antireflux surgery in patients with Barrett's esophagus. Eur Surg-ACA. 2008;40:154-164.
11. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
12. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007;36:666-676.
13. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2014.
14. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1-48.
15. Bagos PG, Nikolopoulos GK. Mixed-effects Poisson regression models for meta-analysis of follow-up studies with constant or varying durations. Int J Biostat. 2009;5:article 21.
16. Kauttu TM, Rantanen TK, Sihvo EI, et al. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis. Eur J Cardiothorac Surg. 2011;40:1450-1454; discussion 1454.
17. Lagergren J, Ye W, Lagergren P, et al. The risk of esophageal adenocarcinoma after antireflux surgery. Gastroenterology. 2010;138:1297-1301.
18. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
19. Williamson WA, Ellis Jr FH, Gibb SP, et al. Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg. 1990;49:537-541; discussion 541-542.
20. McCallum RW, Polepalle S, Davenport K, et al. Role of anti-reflux surgery against dysplasia in Barrett's esophagus. Gastroenterology. 1991;100:A121.
21. Attwood SE, Barlow AP, Norris TL, et al. Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg. 1992;79:1050-1053.
22. Gurski RR, Peters JH, Hagen JA, et al. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg. 2003;196:706-712; discussion 712-713.
23. Tran T, Spechler SJ, Richardson P, et al. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a veterans affairs cohort study. Am J Gastroenterol. 2005;100:1002-1008.
24. Oberg S, Wenner J, Johansson J, et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg. 2005;242:49-54.
25. Gatenby PA, Ramus JR, Caygill CP, et al. Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus. Dis Esophagus. 2009;22:133-142.
26. Ye W, Chow WH, Lagergren J, et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001;121:1286-1293.
27. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a random-ized controlled trial. JAMA. 2001;285:2331-2338.
28. Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg. 2003;237:291-298.
29. Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014;63:1229-1237.
30. Jurgens S, Meyer F, Spechler SJ, et al. The role of bile acids in the neoplastic progression of Barrett's esophagus: a short representative overview. Z Gastro-enterol. 2012;50:1028-1034.
31. Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305:1969-1977.
32. Lofdahl HE, Lu Y, Lagergren P, et al. Risk factors for esophageal adenocarcinoma after antireflux surgery. Ann Surg. 2013;257:579-582.
33. Lagergren J, Viklund P. Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux? World J Surg. 2007;31:465-469.
34. Wileman SM, McCann S, Grant AM, et al. Medical versus surgical manage-ment for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2010. CD003243.